HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic and circulatory effects of intravenous and oral salbutamol in late pregnancy in diabetic and non-diabetic women.

Abstract
The present study investigated the cardiovascular and metabolic "side-effects" of the beta 2-adrenoceptor stimulating drug salbutamol in the third trimester of pregnancy in diabetic and non-diabetic women. Salbutamol was administered either orally or as an intravenous infusion. Blood samples were collected for analyses of plasma cyclic AMP, insulin, C-peptide, and carbohydrate and lipid metabolites. Fetal heart rate, maternal heart rate, and blood pressure were registered simultaneously. After both intravenous and oral salbutamol, there was a statistically significant decrease in diastolic blood pressure, increase in maternal heart rate, plasma levels of cyclic AMP, insulin, and carbohydrate and lipid metabolites showing stimulation of glycogenolysis, lipolysis, and insulin secretion. The increase in fetal heart rate was slight. In diabetic women, the glycogenolytic and lipolytic effects of salbutamol were significantly more pronounced than in non-diabetics. The acute maternal circulatory and metabolic effects after salbutamol are probably too slight to have any clinical significance in healthy women. However, in diabetics, due to their impaired insulin function, a serious metabolic deterioration after salbutamol might occur.
AuthorsJ Wager, B Fredholm, N O Lunell, B Persson
JournalActa obstetricia et gynecologica Scandinavica. Supplement (Acta Obstet Gynecol Scand Suppl) Vol. 108 Pg. 41-6 ( 1982) ISSN: 0300-8835 [Print] Denmark
PMID6957128 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Albuterol
Topics
  • Administration, Oral
  • Albuterol (administration & dosage, pharmacology)
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Injections, Intravenous
  • Maternal-Fetal Exchange
  • Pregnancy
  • Pregnancy Trimester, Third
  • Pregnancy in Diabetics (blood, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: